Crossmark

Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway

Published Online: 2021-02-05

Published Print: 2021-05

Authors

Yi, Xianglan

Lou, Liping

Wang, Jun

Xiong, Jing

Zhou, Sheng https://orcid.org/0000-0001-7369-2413
Funding

Funding for this research was provided by:

Natural Science Foundation of Hubei Province (2019CFB548)

National Natural Science Foundation of China (81874117)

National Natural Science Foundation of China (81974419)
License Information

Text and Data Mining valid from 2021-02-05

Version of Record valid from 2021-02-05
More Information

Article History

Received: 12 September 2020

Accepted: 20 January 2021

First Online: 5 February 2021

Compliance with ethical standards

:

: No potential conflicts of interest were disclosed.

Document is current